A placebo-controlled patency study of intravenous anisoylated plasminogen streptokinase activator complex 30U in acute myocardial infarction.
de Bono, D P
A placebo-controlled patency study of intravenous anisoylated plasminogen streptokinase activator complex 30U in acute myocardial infarction. [electronic resource] - Drugs 1987 - 138-9 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
0012-6667
10.2165/00003495-198700333-00022 doi
Anistreplase
Clinical Trials as Topic
Coronary Angiography
Fibrinolytic Agents--therapeutic use
Humans
Injections, Intravenous
Myocardial Infarction--drug therapy
Plasminogen--therapeutic use
Random Allocation
Streptokinase--therapeutic use
Vascular Patency--drug effects
A placebo-controlled patency study of intravenous anisoylated plasminogen streptokinase activator complex 30U in acute myocardial infarction. [electronic resource] - Drugs 1987 - 138-9 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
0012-6667
10.2165/00003495-198700333-00022 doi
Anistreplase
Clinical Trials as Topic
Coronary Angiography
Fibrinolytic Agents--therapeutic use
Humans
Injections, Intravenous
Myocardial Infarction--drug therapy
Plasminogen--therapeutic use
Random Allocation
Streptokinase--therapeutic use
Vascular Patency--drug effects